InnoCan Pharma Corporation
INNPF
$0.14
$0.0086.06%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.54% | 12.93% | 18.28% | -3.45% | 19.30% |
| Total Receivables | 66.74% | -53.04% | 32.85% | 46.11% | 5.32% |
| Inventory | 28.75% | 2.27% | 48.94% | 3.80% | 18.77% |
| Prepaid Expenses | -9.22% | -68.60% | 92.94% | -16.26% | -2.64% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -19.05% | -23.36% | -0.72% | -4.17% | 41.18% |
| Total Current Assets | 10.27% | -3.57% | 30.98% | 1.07% | 16.88% |
|
|
|||||
| Total Current Assets | 10.27% | -3.57% | 30.98% | 1.07% | 16.88% |
| Net Property, Plant & Equipment | -3.28% | -4.69% | -5.88% | 1.49% | -5.63% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 10.08% | -3.58% | 30.26% | 1.08% | 16.33% |
|
|
|||||
| Total Accounts Payable | -66.07% | -18.45% | 325.89% | -66.37% | 88.14% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 10.47% | -40.71% | 97.79% | -3.57% | 189.94% |
| Total Other Current Liabilities | 10.47% | -40.71% | 97.79% | -3.57% | 189.94% |
| Total Current Liabilities | -0.67% | -38.26% | 70.11% | 8.17% | 169.30% |
|
|
|||||
| Total Current Liabilities | -0.67% | -38.26% | 70.11% | 8.17% | 169.30% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -75.00% | -42.86% | -36.36% | -31.25% | -38.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.79% | -38.26% | 69.66% | 7.90% | 163.29% |
|
|
|||||
| Common Stock & APIC | 1.57% | 0.97% | 4.77% | 1.87% | 3.76% |
| Retained Earnings | -0.84% | 0.97% | -5.34% | -2.74% | -6.72% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 6.76% | 17.39% | 0.19% | -4.65% | -14.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 6.76% | 17.39% | 0.19% | -4.65% | -14.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 47.24% | 103.86% | 110.60% | 44.39% | 5,000.00% |
| Total Equity | 14.90% | 28.34% | 7.32% | -2.51% | -10.07% |
|
|
|||||
